C4 Therapeutics
1D
1W
1M
3M
1Y
5Y
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CCCC and other ETFs, options, and stocks.About CCCC
C4 Therapeutics, Inc. engages in the development of targeted protein degradation science to develop a new generation of small molecule medicines used for treating diseases. It develops the Degronimid platform that incorporates small molecule binders to target disease-causing proteins and facilitate their destruction and clearance from the cell through the natural ubiquitin and proteasome system.
CEOAndrew J. Hirsch
CEOAndrew J. Hirsch
Employees121
Employees121
HeadquartersWatertown, Massachusetts
HeadquartersWatertown, Massachusetts
Founded2015
Founded2015
Employees121
Employees121
CCCC Key Statistics
Market cap381.38M
Market cap381.38M
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume351.06K
Average volume351.06K
High today—
High today—
Low today—
Low today—
Open price$7.94
Open price$7.94
Volume0.00
Volume0.00
52 Week high$26.80
52 Week high$26.80
52 Week low$4.84
52 Week low$4.84
Analyst ratings
54%
of 13 ratingsBuy
53.8%
Hold
30.8%
Sell
15.4%
CCCC Earnings
-$0.69
-$0.46
-$0.23
$0.00
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated— per share
Estimated— per share
ActualExpected Feb 23, Pre-Market
ActualExpected Feb 23, Pre-Market